Diabetes: We need to do better, says CIHI reportCanada has one of the highest prevalence rates among developed countries Remembrance: Thanks to Canada's doctors—from Serbia Dear Health Minister: please reinstate funding for Cochrane Canada Cochrane is a key global healthcare resource that needs Canada’s involvement. Meet the two doctors appointed to Justin Trudeau’s Liberal cabinet Entresto: novel combination product for heart failure First angiotensin receptor-neprilysin inhibitor reduces mortality and heart failure hospitalization. Off-label drugs contribute to adverse drug events in adults, study finds Saskatoon children with rare disease to have costly drug covered by province Government to cover unproven drug for siblings with rare, deadly blood disease. US study finds pharmacist interventions pay dividends New research finds delivering combination of services for patients started new treatment course saves money, reduces healthcare utilization. Valeant sends letter in an attempt to reassure U.S. health care professionals Company offers reassurance patients will continue to have access to medicines. Catastrophic pharmacare is a catastrophe Why the provinces don’t need $3 billion in federal tax dollars for flawed prescription drug policies. First Previous 2320 2321 2322 2323 2324 Next Last
